Upgrading the pharma industry with automation and real-time information
In many ways the highly innovative, trillion-dollar pharmaceutical industry is a picture of modernity; yet it is lagging behind other business sectors in some basic infrastructure and processes.
COVID-19 has only accentuated the impact of information not freely flowing in healthcare ecosystems. We saw this issue in many countries, including the US with COVID-19 test results. As demand for COVID-19 tests soared, wait times to get test results back were hampered by a lack of technology and outdated processes. One bottleneck in the process to get back test results? An over-reliance on fax machines.
Even in Australia, with test results delivered electronically, acting on those results is usually a manual process. With regular testing critical to the safety of some medications, that can be problematic.
While other industries have moved into the age of technology, big data and real-time information, in many ways the life sciences and healthcare industry have not modernised. This is where our technology comes into the picture.
Built on InterSystems’ IRIS for Health, our highly configurable apps and portals support specialty medicines for patients, caregivers, healthcare providers (HCPs), nurse support teams, field teams and pharmaceutical companies. We’re proud of our ability to integrate with labs and receive real-time information about patient test results in our solutions.
This critical, real-time access to data can substantially benefit the pharmaceutical industry. For some patients on experimental new medicines, the careful monitoring of test results can mean the difference between detecting an adverse event and treatment success. Real-time information is of vital importance to patients and care teams alike.
Our Chameleon platform provides automated risk management to keep patients safe throughout complex specialty treatments while integrating with labs and other vendors in real time. Plus, it adapts to the unique look of brands, which results in technology that matches pharmaceutical companies’ products.
Key to the platform’s effectiveness is the ability to adapt to the unique workflows and journeys of patients and doctors. By focusing on getting the right information to the right person at the right time, doctors and patients can focus on the most important matters at hand.
In one of our Australian-based programs, we’re working with a pharmaceutical partner to help coordinate thousands of patients for scheduled infusions on specific dates using our technology — a task that normally would be performed by the healthcare team. This function allows the healthcare team to manage many more patients when simple administrative tasks are automated and, instead, they are able to spend time with patients who need their care.
Patients receive reminders about the upcoming infusion appointments and use our patient app to review product information, access educational materials, schedule their next infusion and report any adverse events. All of this patient app data — such as infusion dates and any adverse events that the patient logs — is automatically updated in the HCP portal to keep the care team in sync with the patients and know when a patient receives (or misses) a scheduled infusion.
The result has been a highly successful program that manages thousands of patients who are engaged in their treatment and highly compliant with making their scheduled infusions.
Patients receive care on the timeline needed for the best possible medical outcomes, doctors are kept well-informed of their patients’ progress, and pharmaceutical companies see patients adhering to high-need, specialty treatments. It’s the type of solution that wouldn’t be possible without technology and real-time data exchanges.
We think the future of all specialty medicines will include digital companion apps to support patients and help them adhere to complex treatments. These apps will allow more data to be shared in real time and greater communication with the healthcare team to ensure patient safety.
That’s a situation where everyone wins — patients, doctors and the pharma industry.
Concept to clinical care: what's holding back healthtech?
Australia is globally recognised for its exceptional medical research output. So why isn't...
Why more needs to be done to support home-grown innovations
Commercialising new medical devices or drugs is highly risky, extremely expensive and returns can...
Opinion: Securing the backbone of health care
Unified, reliable databases provide healthcare organisations with immediate access to...
